Skip to main content
. 2007 Nov 20;98(2):489–495. doi: 10.1038/sj.bjc.6604115

Figure 2.

Figure 2

Kaplan–Meier survival curve for ovarian carcinoma patients according to E-cadherin immunoreactivity in primary ovarian cancers. Discontinuous line represents preserved E-cadherin immunoreactivity (3+). Continuous line represents reduced E-cadherin immunoreactivity (2+, 1+, and 0). Patients with reduced E-cadherin immunoreactivity had a significantly shorter overall survival (P=0.008).